Mild cognitive impairment: a neuropsychological perspective

Aaron P Nelson1, Margaret G O'Connor

  • 1Brigham and Women's Hospital, Division of Cognitive and Behavioral Neurology, Boston, MA 02115, USA. anelson@partners.org

CNS Spectrums
|January 22, 2008
PubMed

Insights

Mild cognitive impairment (MCI) is a transitional stage before dementia, often Alzheimer's disease. Comprehensive neuropsychological testing is crucial for early detection and tracking cognitive changes.

Area of Science:

  • Neurology
  • Gerontology
  • Neuropsychology

Background:

  • Mild cognitive impairment (MCI) signifies cognitive deficits not severe enough for dementia.
  • MCI often represents a preclinical stage of Alzheimer's disease or other dementias.
  • Recognized subtypes of MCI extend beyond memory to include executive function, language, and visuospatial domains.

Purpose of the Study:

  • To highlight the diagnostic utility of neuropsychological testing in MCI.
  • To emphasize the importance of comprehensive cognitive assessment.
  • To underscore the critical role of early MCI identification for potential therapeutic interventions.

Main Methods:

  • Utilizing a comprehensive neuropsychological test battery.
  • Assessing baseline intellectual ability, attention, executive function, memory, language, and visuospatial skills.
  • Incorporating informant-based measures of neuropsychiatric symptoms and functional competency.

Main Results:

  • Neuropsychological testing effectively identifies subtle cognitive deficits in MCI.
  • Comprehensive assessment aids in tracking the evolution of cognitive symptoms over time.
  • Early detection is vital, especially in individuals with high baseline intellectual function.

Conclusions:

  • Comprehensive neuropsychological evaluation is essential for accurate MCI diagnosis and monitoring.
  • Early identification of MCI is critical for timely intervention, particularly with emerging Alzheimer's disease therapies.
  • Subtle cognitive changes indicative of MCI can be detected through detailed assessment.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Cognitivism01:17

Cognitivism

Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process information is...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...